Status:
COMPLETED
Time to Surgery and Survival Outcomes for Patients With Resected Colorectal Carcinoma: Multicenter Study (BIG RENAPE)
Lead Sponsor:
Institut Cancerologie de l'Ouest
Collaborating Sponsors:
Hospices Civils de Lyon
Conditions:
Colo-rectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Colorectal cancer (CRC) is diagnosed in one million patients each year worldwide and is the 2nd leading cause of cancer death. Peritoneal metastasis (MP) is seen in 10% of CRC patients and is the meta...
Detailed Description
This is a retrospective study including exhaustively all patients operated CC0-CC1 of peritoneal carcinosis between 2007 and 2019 meeting the inclusion criteria: * Patients from the Institut de cancé...
Eligibility Criteria
Inclusion
- Age \>18 years
- Histological evidence of peritoneal metastases
- Primary colorectal cancer
- Surgical cytoreduction CC0 or CC1
Exclusion
- Patient who has not received at least 3 courses of pre and/or post cytoreduction chemotherapy
- Primitive appendicitis
- Unknown primitive
- Patient with incomplete CC2 and/or palliative surgery
- Patient opposed to the use of their data for research.
- Isolated local pelvic recurrence.
- Extraperitoneal metastases not resected or destroyed before or during cytoreduction.
- Patient opposed to the use of his/her data for research purposes
Key Trial Info
Start Date :
June 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 10 2022
Estimated Enrollment :
227 Patients enrolled
Trial Details
Trial ID
NCT04916054
Start Date
June 4 2021
End Date
March 10 2022
Last Update
September 5 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU LYON
Lyon, France
2
Institut de Cancerologie de L'Ouest
Saint-Herblain, France